Breaking News Instant updates and real-time market news.

MNGPF

Man Group

$0.00 /

+ (+0.00%)

13:34
03/03/21
03/03
13:34
03/03/21
13:34

Man Group price target raised to 180 GBp from 170 GBp at JPMorgan

JPMorgan analyst Gurjit Kambo raised the firm's price target on Man Group to 180 GBp from 170 GBp and keeps an Overweight rating on the shares.

MNGPF Man Group
$0.00 /

+ (+0.00%)

03/03/21 Credit Suisse
Man Group price target raised to 175 GBp from 160 GBp at Credit Suisse
02/22/21 Barclays
Man Group price target raised to 160 GBp from 145 GBp at Barclays
02/01/21 Berenberg
Man Group price target raised to 163 GBp from 138 GBp at Berenberg
12/17/20 Credit Suisse
Man Group upgraded to Outperform from Neutral at Credit Suisse

TODAY'S FREE FLY STORIES

Recommendations
Danaher price target raised to $315 from $275 at Citi » 06:32
04/23/21
04/23
06:32
04/23/21
06:32
DHR

Danaher

$252.83 /

+8.21 (+3.36%)

Citi analyst Patrick…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DHR Danaher
$252.83 /

+8.21 (+3.36%)

DHR Danaher
$252.83 /

+8.21 (+3.36%)

04/08/21 Citi
Citi opens 'positive catalyst watch' on Danaher, sees Q1 beat
04/07/21 Baird
Danaher assumed with an Outperform at Baird
03/18/21 KeyBanc
Thermo Fisher upgraded to Overweight at KeyBanc after Sartorius guidance
03/02/21 Barclays
Danaher started at Overweight at Barclays on GE biopharma business potential
DHR Danaher
$252.83 /

+8.21 (+3.36%)

  • 08
    May
DHR Danaher
$252.83 /

+8.21 (+3.36%)

DHR Danaher
$252.83 /

+8.21 (+3.36%)

Initiation
Arista Networks resumed with an Overweight at KeyBanc » 06:32
04/23/21
04/23
06:32
04/23/21
06:32
ANET

Arista Networks

$312.95 /

-3.46 (-1.09%)

KeyBanc analyst Steve…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ANET Arista Networks
$312.95 /

-3.46 (-1.09%)

ANET Arista Networks
$312.95 /

-3.46 (-1.09%)

04/20/21 B. Riley
B. Riley says buy NeoPhotonics as 'industry titans clash'
04/13/21 Cowen
Arista Networks return to strong growth seen, says Cowen
03/26/21 JPMorgan
Bearish sentiment on Arista ignores 'strong growth,' says JPMorgan
03/24/21 Cleveland Research
Arista Networks partner feedback 'encouraging,' says Cleveland Research
ANET Arista Networks
$312.95 /

-3.46 (-1.09%)

ANET Arista Networks
$312.95 /

-3.46 (-1.09%)

Upgrade
Societe Generale upgrades Hermes to Buy citing accelerating momentum » 06:32
04/23/21
04/23
06:32
04/23/21
06:32
HESAY

Hermes

$126.75 /

+2.19 (+1.76%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HESAY Hermes
$126.75 /

+2.19 (+1.76%)

05:13 Today Societe Generale
Hermes upgraded to Buy from Hold at Societe Generale
04/09/21 BofA
Hermes upgraded to Buy from Neutral at BofA
04/08/21 Oddo BHF
Hermes upgraded to Outperform from Neutral at Oddo BHF
04/07/21 Deutsche Bank
Hermes price target raised to EUR 760 from EUR 700 at Deutsche Bank
Recommendations
Core Laboratories price target lowered to $30 from $36 at Citi » 06:31
04/23/21
04/23
06:31
04/23/21
06:31
CLB

Core Laboratories

$26.99 /

-0.08 (-0.30%)

Citi analyst Scott Gruber…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CLB Core Laboratories
$26.99 /

-0.08 (-0.30%)

CLB Core Laboratories
$26.99 /

-0.08 (-0.30%)

01/11/21 Wolfe Research
Core Laboratories upgraded to Peer Perform from Underperform at Wolfe Research
12/18/20 JPMorgan
Core Laboratories downgraded to Underweight with $18 target at JPMorgan
12/18/20 JPMorgan
Core Laboratories downgraded to Underweight from Neutral at JPMorgan
12/15/20 Citi
Core Laboratories price target raised to $30 from $16 at Citi
CLB Core Laboratories
$26.99 /

-0.08 (-0.30%)

CLB Core Laboratories
$26.99 /

-0.08 (-0.30%)

Upgrade
Vossloh upgraded to Buy from Hold at Deutsche Bank » 06:30
04/23/21
04/23
06:30
04/23/21
06:30
VOSSF

Vossloh

$51.25 /

+ (+0.00%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Upgrade
Silicon Labs upgraded to Overweight from Sector Weight at KeyBanc » 06:29
04/23/21
04/23
06:29
04/23/21
06:29
SLAB

Silicon Labs

$144.81 /

-3.1 (-2.10%)

KeyBanc analyst John Vinh…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SLAB Silicon Labs
$144.81 /

-3.1 (-2.10%)

SLAB Silicon Labs
$144.81 /

-3.1 (-2.10%)

04:42 Today KeyBanc
Silicon Labs upgraded to Overweight from Sector Weight at KeyBanc
02/24/21 Wells Fargo
Silicon Labs price target raised to $180 from $165 at Wells Fargo
02/22/21 Needham
Silicon Labs price target raised to $195 from $150 at Needham
02/22/21 Benchmark
Silicon Labs price target raised to $190 from $155 at Benchmark
SLAB Silicon Labs
$144.81 /

-3.1 (-2.10%)

SLAB Silicon Labs
$144.81 /

-3.1 (-2.10%)

SLAB Silicon Labs
$144.81 /

-3.1 (-2.10%)

Initiation
First of America initiated with an Outperform at Raymond James » 06:29
04/23/21
04/23
06:29
04/23/21
06:29
FOA

First of America

$10.16 /

+0.18 (+1.80%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FOA First of America
$10.16 /

+0.18 (+1.80%)

FOA First of America
$10.16 /

+0.18 (+1.80%)

Downgrade
Workspace Group downgraded to Underweight from Overweight at Barclays » 06:28
04/23/21
04/23
06:28
04/23/21
06:28
WKPPF

Workspace Group

$10.90 /

+ (+0.00%)

Barclays analyst Paul May…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WKPPF Workspace Group
$10.90 /

+ (+0.00%)

02/17/21 Jefferies
Workspace Group upgraded to Buy on pent up office space demand at Jefferies
02/16/21 Jefferies
Workspace Group upgraded to Buy from Hold at Jefferies
12/16/20 JPMorgan
Workspace Group price target raised to 820 GBp from 700 GBp at JPMorgan
12/10/20 Berenberg
Workspace Group downgraded to Sell from Hold at Berenberg
Downgrade
Lufthansa downgraded to Hold from Buy at Kepler Cheuvreux » 06:27
04/23/21
04/23
06:27
04/23/21
06:27
DLAKY

Lufthansa

$12.72 /

+0.24 (+1.92%)

Kepler Cheuvreux analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DLAKY Lufthansa
$12.72 /

+0.24 (+1.92%)

04/21/21 Barclays
Lufthansa price target raised to EUR 7 from EUR 6.20 at Barclays
03/31/21 AlphaValue
Lufthansa upgraded to Reduce from Sell at AlphaValue
03/24/21 Commerzbank
Lufthansa downgraded to Reduce from Hold at Commerzbank
03/23/21 Citi
Citi opens '90-day negative Catalyst Watch' on Lufthansa
DLAKY Lufthansa
$12.72 /

+0.24 (+1.92%)

Upgrade
Veolia Environment upgraded to Overweight from Equal Weight at Barclays » 06:27
04/23/21
04/23
06:27
04/23/21
06:27
VEOEY

Veolia Environment

$30.12 /

+0.414 (+1.39%)

Barclays analyst Peter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VEOEY Veolia Environment
$30.12 /

+0.414 (+1.39%)

VEOEY Veolia Environment
$30.12 /

+0.414 (+1.39%)

04/13/21 Bryan Garnier
Veolia Environment downgraded to Neutral from Buy at Bryan Garnier
03/08/21 Barclays
Veolia Environment price target raised to EUR 24 from EUR 22.50 at Barclays
02/26/21 DZ Bank
Veolia Environment upgraded to Buy from Hold at DZ Bank
02/16/21 Berenberg
Veolia Environment price target raised to EUR 30 from EUR 21 at Berenberg
Upgrade
Verbund upgraded to Hold from Sell at Societe Generale » 06:27
04/23/21
04/23
06:27
04/23/21
06:27
OEZVY

Verbund

$16.00 /

-0.725 (-4.34%)

Societe Generale analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OEZVY Verbund
$16.00 /

-0.725 (-4.34%)

05:12 Today Societe Generale
Verbund upgraded to Hold from Sell at Societe Generale
03/18/21 Barclays
Verbund price target lowered to EUR 55 from EUR 56 at Barclays
03/18/21 Oddo BHF
Verbund downgraded to Underperform from Neutral at Oddo BHF
03/10/21 Credit Suisse
Verbund price target raised to EUR 46.50 from EUR 43.50 at Credit Suisse
Downgrade
CaixaBank downgraded to Neutral from Outperform at Credit Suisse » 06:26
04/23/21
04/23
06:26
04/23/21
06:26
CAIXY

CaixaBank

$1.01 /

+ (+0.00%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CAIXY CaixaBank
$1.01 /

+ (+0.00%)

04/07/21 Morgan Stanley
CaixaBank resumed with an Overweight at Morgan Stanley
04/06/21 Barclays
CaixaBank price target raised to EUR 3 from EUR 2.70 at Barclays
03/26/21 JPMorgan
CaixaBank price target raised to EUR 2.80 from EUR 2.65 at JPMorgan
03/05/21 Berenberg
CaixaBank price target raised to EUR 2.45 from EUR 1.85 at Berenberg
Downgrade
EVN AG downgraded to Equal Weight from Overweight at Barclays » 06:26
04/23/21
04/23
06:26
04/23/21
06:26
EVNVY

EVN AG

$4.30 /

+ (+0.00%)

Barclays analyst Peter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EVNVY EVN AG
$4.30 /

+ (+0.00%)

12/18/20 Barclays
EVN AG upgraded to Overweight from Equal Weight at Barclays
12/17/20 Kepler Cheuvreux
EVN AG upgraded to Buy from Hold at Kepler Cheuvreux
Conference/Events
UBS chief economists to hold an analyst/industry conference call » 06:25
04/23/21
04/23
06:25
04/23/21
06:25

Chief Economists Kapteyn…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Recommendations
G1 Therapeutics transferred with Outperform at Cowen » 06:24
04/23/21
04/23
06:24
04/23/21
06:24
GTHX

G1 Therapeutics

$22.69 /

+0.16 (+0.71%)

Cowen analyst Joseph…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GTHX G1 Therapeutics
$22.69 /

+0.16 (+0.71%)

GTHX G1 Therapeutics
$22.69 /

+0.16 (+0.71%)

11/17/20 Raymond James
Raymond James downgrades G1 Therapeutics after removing rintodestrant from model
11/17/20 Raymond James
G1 Therapeutics downgraded to Outperform from Strong Buy at Raymond James
07/01/20 Wedbush
G1 Therapeutics price target lowered to $50 from $55 at Wedbush
06/26/20 Roth Capital
G1 Therapeutics initiated with a Buy at Roth Capital
GTHX G1 Therapeutics
$22.69 /

+0.16 (+0.71%)

Syndicate
EDAP TMS 4.15M share Spot Secondary priced at $6.75 » 06:23
04/23/21
04/23
06:23
04/23/21
06:23
EDAP

EDAP TMS

$8.40 /

-0.05 (-0.59%)

Piper Sandler acted as…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EDAP EDAP TMS
$8.40 /

-0.05 (-0.59%)

EDAP EDAP TMS
$8.40 /

-0.05 (-0.59%)

04/01/21 H.C. Wainwright
EDAP TMS price target raised to $12 from $10 at H.C. Wainwright
01/25/21 Lake Street
EDAP TMS initiated with a Buy at Lake Street
01/22/21 B. Riley Securities
EDAP TMS price target raised to $13 from $11.50 at B. Riley Securities
01/12/21 B. Riley Securities
EDAP TMS price target raised to $11.50 from $5.50 at B. Riley Securities
EDAP EDAP TMS
$8.40 /

-0.05 (-0.59%)

  • 23
    Apr
EDAP EDAP TMS
$8.40 /

-0.05 (-0.59%)

Recommendations
Y-mAbs Therapeutics transferred with Outperform at Cowen » 06:23
04/23/21
04/23
06:23
04/23/21
06:23
YMAB

Y-mAbs Therapeutics

$27.03 /

+0.3 (+1.12%)

Cowen analyst Joseph…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
YMAB Y-mAbs Therapeutics
$27.03 /

+0.3 (+1.12%)

YMAB Y-mAbs Therapeutics
$27.03 /

+0.3 (+1.12%)

04/21/21 Wedbush
Y-mAbs Therapeutics price target lowered to $52 from $67 at Wedbush
03/22/21 JPMorgan
Y-mAbs Therapeutics assumed with an Overweight at JPMorgan
03/01/21 H.C. Wainwright
Y-mAbs Therapeutics price target raised to $70 from $65 at H.C. Wainwright
01/15/21 BofA
BofA cuts Y-mAbs Therapeutics to Neutral with near-term catalysts played out
YMAB Y-mAbs Therapeutics
$27.03 /

+0.3 (+1.12%)

  • 18
    Feb
YMAB Y-mAbs Therapeutics
$27.03 /

+0.3 (+1.12%)

YMAB Y-mAbs Therapeutics
$27.03 /

+0.3 (+1.12%)

Upgrade
SEB SA upgraded to Buy from Hold at Societe Generale » 06:23
04/23/21
04/23
06:23
04/23/21
06:23
SEBYF

SEB SA

$171.25 /

+ (+0.00%)

Societe Generale analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SEBYF SEB SA
$171.25 /

+ (+0.00%)

05:11 Today Societe Generale
SEB SA upgraded to Buy from Hold at Societe Generale
03/31/21 UBS
SEB SA price target raised to SEK 100 from SEK 91 at UBS
03/10/21 Societe Generale
SEB SA price target lowered to EUR 144 from EUR 158 at Societe Generale
03/08/21 Morgan Stanley
SEB SA price target raised to SEK 100 from SEK 92 at Morgan Stanley
Recommendations
Epizyme transferred with Outperform at Cowen » 06:21
04/23/21
04/23
06:21
04/23/21
06:21
EPZM

Epizyme

$7.88 /

-0.005 (-0.06%)

Cowen analyst Joe Thome…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EPZM Epizyme
$7.88 /

-0.005 (-0.06%)

EPZM Epizyme
$7.88 /

-0.005 (-0.06%)

03/30/21 Credit Suisse
Epizyme initiated with an Outperform at Credit Suisse
03/30/21 Credit Suisse
Epizyme initiated with an Outperform at Credit Suisse
02/25/21 Morgan Stanley
Epizyme downgraded to Equal Weight on Tazverik challenges at Morgan Stanley
02/25/21 Morgan Stanley
Epizyme downgraded to Equal Weight from Overweight at Morgan Stanley
EPZM Epizyme
$7.88 /

-0.005 (-0.06%)

EPZM Epizyme
$7.88 /

-0.005 (-0.06%)

Upgrade
Chimerix assumed with Outperform from Market Perform at Cowen » 06:20
04/23/21
04/23
06:20
04/23/21
06:20
CMRX

Chimerix

$8.21 /

-0.05 (-0.61%)

Cowen analyst Joseph…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CMRX Chimerix
$8.21 /

-0.05 (-0.61%)

CMRX Chimerix
$8.21 /

-0.05 (-0.61%)

03/31/21 Jefferies
Jefferies starts Chimerix at Buy with $21 price target
03/31/21 Wedbush
Wedbush bullish on Chimerix, initiates with an Outperform
03/31/21 Jefferies
Chimerix initiated with a Buy at Jefferies
03/31/21 Wedbush
Chimerix initiated with an Outperform at Wedbush
CMRX Chimerix
$8.21 /

-0.05 (-0.61%)

  • 21
    Jan
CMRX Chimerix
$8.21 /

-0.05 (-0.61%)

Initiation
Argenx initiated with a Neutral at Redburn » 06:20
04/23/21
04/23
06:20
04/23/21
06:20
ARGX

Argenx

$295.26 /

+5.52 (+1.91%)

Redburn analyst Charles…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ARGX Argenx
$295.26 /

+5.52 (+1.91%)

ARGX Argenx
$295.26 /

+5.52 (+1.91%)

03/05/21 H.C. Wainwright
Argenx price target raised to $320 from $265 at H.C. Wainwright
02/18/21 Cowen
Argenx price target raised to $430 from $317 at Cowen
02/10/21 Barclays
Argenx price target raised to EUR 295 from EUR 215 at Barclays
02/04/21 Piper Sandler
Argenx price target raised to $309 from $303 at Piper Sandler
  • 03
    Feb
  • 28
    May
ARGX Argenx
$295.26 /

+5.52 (+1.91%)

Initiation
Adicet Bio initiated with a Buy at H.C. Wainwright » 06:18
04/23/21
04/23
06:18
04/23/21
06:18
ACET

Adicet Bio

$13.18 /

+0.38 (+2.97%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ACET Adicet Bio
$13.18 /

+0.38 (+2.97%)

ACET Adicet Bio
$13.18 /

+0.38 (+2.97%)

04/14/21 Canaccord
Canaccord starts Adicet at Buy on 'highly favorable' CAR-T prospects
04/14/21 Canaccord
Adicet Bio initiated with a Buy at Canaccord
04/08/21 Guggenheim
Adicet Bio initiated with a Buy at Guggenheim
11/04/20
Fly Intel: Top five analyst initiations
  • 10
    Feb
  • 24
    Sep
ACET Adicet Bio
$13.18 /

+0.38 (+2.97%)

Periodicals
Two U.S. senators raise concerns over Tesla's autopilot, WSJ reports » 06:17
04/23/21
04/23
06:17
04/23/21
06:17
TSLA

Tesla

$719.79 /

-24.37 (-3.27%)

Two U.S. senators have…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TSLA Tesla
$719.79 /

-24.37 (-3.27%)

TSLA Tesla
$719.79 /

-24.37 (-3.27%)

04/22/21 Morgan Stanley
Tesla price target raised to $900 from $880 at Morgan Stanley
04/22/21 Citi
Citi keeps Sell rating, $159 target on Tesla into Q1 results
04/20/21 Mizuho
Tesla price target raised to $820 from $775 at Mizuho
04/13/21 Credit Suisse
Credit Suisse ahead of consensus into Q1 EPS for Tesla
TSLA Tesla
$719.79 /

-24.37 (-3.27%)

TSLA Tesla
$719.79 /

-24.37 (-3.27%)

TSLA Tesla
$719.79 /

-24.37 (-3.27%)

TSLA Tesla
$719.79 /

-24.37 (-3.27%)

Upgrade
Laurentian Bank upgraded to Sector Perform from Underperform at National Bank » 06:16
04/23/21
04/23
06:16
04/23/21
06:16
LRCDF

Laurentian Bank

$34.11 /

+2.06 (+6.43%)

National Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LRCDF Laurentian Bank
$34.11 /

+2.06 (+6.43%)

LRCDF Laurentian Bank
$34.11 /

+2.06 (+6.43%)

04/22/21 RBC Capital
Laurentian Bank upgraded to Outperform from Sector Perform at RBC Capital
04/22/21 RBC Capital
Laurentian Bank upgraded to Outperform from Sector Perform at RBC Capital
03/05/21 Desjardins
Laurentian Bank price target raised to C$41 from C$33 at Desjardins
03/04/21 Credit Suisse
Laurentian Bank price target raised to C$36 from C$30 at Credit Suisse
Earnings
Autoliv reports Q1 adjusted EPS $1.79, consensus $1.42 » 06:16
04/23/21
04/23
06:16
04/23/21
06:16
ALV

Autoliv

$98.25 /

+0.67 (+0.69%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALV Autoliv
$98.25 /

+0.67 (+0.69%)

ALV Autoliv
$98.25 /

+0.67 (+0.69%)

04/15/21 Berenberg
Autoliv initiated with a Hold at Berenberg
03/25/21 Wells Fargo
Autoliv initiated with an Equal Weight at Wells Fargo
03/22/21 Nordea
Autoliv downgraded to Hold from Buy at Nordea
02/02/21 Citi
Autoliv price target raised to $97 from $94 at Citi
ALV Autoliv
$98.25 /

+0.67 (+0.69%)

ALV Autoliv
$98.25 /

+0.67 (+0.69%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.